https://orcid.org/0000-0001-7201-9163
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Luca Potestio, Angelo Ruggiero, Gabriella Fabbrocini, Fabrizio Martora & Matteo Megna. (2023) Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature. Psoriasis: Targets and Therapy 13, pages 19-26.
Read now
Read now
Luca Potestio, Fabrizio Martora, Gabriella Fabbrocini, Teresa Battista & Matteo Megna. (2023) Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis. Psoriasis: Targets and Therapy 13, pages 11-18.
Read now
Read now
Luca Potestio, Matteo Megna, Alessia Villani, Sara Cacciapuoti, Massimiliano Scalvenzi & Fabrizio Martora. (2023) Herpes Zoster and COVID-19 Vaccination: A Narrative Review. Clinical, Cosmetic and Investigational Dermatology 16, pages 3323-3331.
Read now
Read now
Qian Song, Ying Chen, JianQing Ma, Wei Zhou, JunYan Song, ChunFu Wu & Jie Liu. (2023) Metabolomics Reveals Molecular Signatures for Psoriasis Biomarkers and Drug Targets Discovery. Clinical, Cosmetic and Investigational Dermatology 16, pages 3181-3191.
Read now
Read now
Sara Cacciapuoti, Luca Potestio, Gianluca Guerrasio, Gabriella Fabbrocini, Massimiliano Scalvenzi, Angelo Ruggiero, Giuseppina Caiazzo & Matteo Megna. (2023) Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas. Clinical, Cosmetic and Investigational Dermatology 16, pages 2637-2644.
Read now
Read now
Fabrizio Martora, Massimiliano Scalvenzi, Teresa Battista, Luigi Fornaro, Luca Potestio, Angelo Ruggiero & Matteo Megna. (2023) Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data. Clinical, Cosmetic and Investigational Dermatology 16, pages 2525-2536.
Read now
Read now
Teresa Battista, Massimiliano Scalvenzi, Fabrizio Martora, Luca Potestio & Matteo Megna. (2023) Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments. Clinical, Cosmetic and Investigational Dermatology 16, pages 1899-1932.
Read now
Read now
Luca Potestio, Elisa Camela, Sara Cacciapuoti, Luigi Fornaro, Angelo Ruggiero, Fabrizio Martora, Teresa Battista & Matteo Megna. (2023) Biologics for the Management of Erythrodermic Psoriasis: An Updated Review. Clinical, Cosmetic and Investigational Dermatology 16, pages 2045-2059.
Read now
Read now
Matteo Megna, Elisa Camela, Angelo Ruggiero, Teresa Battista, Fabrizio Martora, Sara Cacciapuoti & Luca Potestio. (2023) Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?. Clinical, Cosmetic and Investigational Dermatology 16, pages 1677-1690.
Read now
Read now
Fabrizio Martora, Matteo Megna, Teresa Battista, Luca Potestio, Maria Carmela Annunziata, Claudio Marasca, Alessia Villani & Gabriella Fabbrocini. (2023) Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience. Clinical, Cosmetic and Investigational Dermatology 16, pages 135-148.
Read now
Read now
Luca Potestio, Elisa Camela, Sara Cacciapuoti, Fabrizio Martora, Luigi Guerriero, Luigi Fornaro, Angelo Ruggiero & Matteo Megna. (2023) Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation. Expert Opinion on Drug Safety 22:11, pages 1003-1010.
Read now
Read now
Alessia Villani, Massimiliano Scalvenzi, Giuseppe Micali, Francesco Lacarrubba, Lucia Genco, Angelo Ruggiero, Luigi Fornaro, Gianluca Guerrasio & Luca Potestio. (2023) Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation. Expert Opinion on Drug Safety 22:7, pages 525-531.
Read now
Read now
Elisa Camela, Luca Potestio, Gabriella Fabbrocini, Sabatino Pallotta & Matteo Megna. (2023) The holistic approach to psoriasis patients with comorbidities: the role of investigational drugs. Expert Opinion on Investigational Drugs 32:6, pages 537-552.
Read now
Read now
Angelo Ruggiero, Luca Potestio, Fabrizio Martora, Alessia Villani, Rosita Comune & Matteo Megna. (2023) Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation. Expert Opinion on Drug Safety 22:5, pages 355-362.
Read now
Read now
Matteo Megna, Elisa Camela, Teresa Battista, Lucia Genco, Fabrizio Martora, Matteo Noto, Vincenzo Picone, Angelo Ruggiero, Giuseppe Monfrecola, Gabriella Fabbrocini & Luca Potestio. (2023) Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients. Expert Opinion on Drug Safety 22:1, pages 43-58.
Read now
Read now
Matteo Megna, Elisa Camela, Teresa Battista, Lucia Genco, Fabrizio Martora, Matteo Noto, Vincenzo Picone, Angelo Ruggiero, Giuseppe Monfrecola, Gabriella Fabbrocini & Luca Potestio. (2023) Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients. Expert Opinion on Drug Safety 22:1, pages 25-41.
Read now
Read now
Fabrizio Martora, Teresa Battista, Claudio Marasca, Lucia Genco, Gabriella Fabbrocini & Luca Potestio. (2022) Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature. Clinical, Cosmetic and Investigational Dermatology 15, pages 2369-2382.
Read now
Read now
Sotirios G. Tsiogkas, Eleni K. Karamitrou, Maria G. Grammatikopoulou, Efterpi Zafiriou & Dimitrios P. Bogdanos. Efficacy of tyrosine-kinase-2 and phosphodiesterase-4 inhibitors for scalp psoriasis: a systematic review and meta-analysis. Current Medical Research and Opinion 0:0, pages 1-17.
Read now
Read now
Articles from other publishers (3)
Matteo Megna, Angelo Ruggiero, Teresa Battista, Laura Marano, Sara Cacciapuoti & Luca Potestio. (2023) Long-Term Efficacy and Safety of Risankizumab for Moderate to Severe Psoriasis: A 2-Year Real-Life Retrospective Study. Journal of Clinical Medicine 12:9, pages 3233.
Crossref
Crossref
Zuzana Jiraskova Zakostelska, Zuzana Reiss, Helena Tlaskalova-Hogenova & Filip Rob. (2023) Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?. Dermatology and Therapy 13:4, pages 911-933.
Crossref
Crossref
Katerina Vlami, Kleoniki Pantelidi, Maria Dalamaga, Fani Karagianni, Konstantinos Theodoropoulos, Spyridon Papiris & Evangelia Papadavid. (2023) Psoriatic Insomnia: A Subjective and Objective Sleep Evaluation. Acta Dermato-Venereologica 103, pages adv00864.
Crossref
Crossref